TR199903211T2 - Solutions containing azasteroids. - Google Patents

Solutions containing azasteroids.

Info

Publication number
TR199903211T2
TR199903211T2 TR1999/03211T TR9903211T TR199903211T2 TR 199903211 T2 TR199903211 T2 TR 199903211T2 TR 1999/03211 T TR1999/03211 T TR 1999/03211T TR 9903211 T TR9903211 T TR 9903211T TR 199903211 T2 TR199903211 T2 TR 199903211T2
Authority
TR
Turkey
Prior art keywords
present
azasteroids
solutions containing
invention describes
another aspect
Prior art date
Application number
TR1999/03211T
Other languages
Turkish (tr)
Inventor
Frank Parr Alan
Catherine Rizzolio Michele
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR199903211T2 publication Critical patent/TR199903211T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut bulus, farmasötik olarak aktif aza steroit, polietilen glikol, ve propilen glikolün tedavi edici olarak etkili bir miktarini içeren yeni bir çözeltiyi tarif etmektedir. Baska bir yönden, mevcut bulus, bulusun çözeltisini içeren bir farmasötik bilesimi tarif etmektedir. Baska bir yönden, mevcut bulus mevcut bulusun bilesimi ile doldurulmus bir jelatin kapsülü tarif etmektedir.The present invention describes a new solution containing a therapeutically effective amount of pharmaceutically active steroids, polyethylene glycol, and propylene glycol. In another aspect, the present invention describes a pharmaceutical composition comprising the solution of the invention. In another aspect, the present invention describes a gelatin capsule filled with the composition of the present invention.

TR1999/03211T 1997-08-19 1998-08-17 Solutions containing azasteroids. TR199903211T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717444.5A GB9717444D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
TR199903211T2 true TR199903211T2 (en) 2000-04-21

Family

ID=10817633

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03211T TR199903211T2 (en) 1997-08-19 1998-08-17 Solutions containing azasteroids.

Country Status (10)

Country Link
EP (1) EP1005346A2 (en)
JP (1) JP2002511100A (en)
KR (1) KR20010014079A (en)
CN (1) CN1263466A (en)
AU (1) AU8979698A (en)
BR (1) BR9810285A (en)
CA (1) CA2295023A1 (en)
GB (1) GB9717444D0 (en)
TR (1) TR199903211T2 (en)
WO (1) WO1999008684A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (en) * 2002-11-22 2004-05-23 Omega Farma Ehf. Compositions of finasteride tablets
CZ300438B6 (en) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Process for preparing solid medicament form for oral administration with instantaneous release of active substance and containing as the active substance finasteride polymorphous form
WO2005066195A1 (en) * 2004-01-02 2005-07-21 Pharmacon Forschung Und Beratung Gmbh Method for producing 1,2-unsaturated azasteroids
EP2050436A1 (en) 2007-12-21 2009-04-22 Siegfried Generics International AG Pharmaceutical composition containing dutasteride
DE102008059201A1 (en) 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ precipitating drug solutions
KR101055412B1 (en) * 2010-11-19 2011-08-08 (주)비씨월드제약 Self-emulsifying emulsion composition comprising dutasteride and preparation method thereof
CN103169712B (en) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 Improve dutasteride's preparation of bioavilability and preparation method thereof
US9808529B2 (en) * 2012-05-18 2017-11-07 Luoda Pharma Pty Ltd Liquid formulation
CN103479595B (en) * 2012-06-13 2015-08-26 成都国弘医药有限公司 A kind of soft capsule containing dutasteride
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
CN103830201A (en) * 2012-11-20 2014-06-04 重庆医药工业研究院有限责任公司 Dutasteride liquid soft capsules
ES2555485T1 (en) 2014-05-26 2016-01-04 Galenicum Health S.L. Pharmaceutical compositions containing an active agent
JP7017938B2 (en) * 2018-01-15 2022-02-09 森下仁丹株式会社 3-oxo-4-azaandrost-1-ene-17-carboxylic acid derivative-containing preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516768A (en) * 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
AU7078296A (en) * 1995-09-27 1997-04-17 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
AU5369198A (en) * 1996-12-09 1998-07-03 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss

Also Published As

Publication number Publication date
GB9717444D0 (en) 1997-10-22
CN1263466A (en) 2000-08-16
KR20010014079A (en) 2001-02-26
WO1999008684A2 (en) 1999-02-25
JP2002511100A (en) 2002-04-09
BR9810285A (en) 2000-09-12
WO1999008684A3 (en) 1999-06-10
AU8979698A (en) 1999-03-08
EP1005346A2 (en) 2000-06-07
CA2295023A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
DE3484779D1 (en) PHARMACEUTICAL AGENTS.
TR199903211T2 (en) Solutions containing azasteroids.
TR200000517T2 (en) Pharmaceutical composition for the combination of piperidinoalkanol-Congestion reducer.
NZ280610A (en) Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
FR2760193B1 (en) LIPIDS AND COMPLEXES OF CATIONIC LIPIDS AND ACTIVE SUBSTANCES, IN PARTICULAR FOR THE TRANSFECTION OF CELLS
TR200100931T2 (en) New sustained release oral formulations
IL128801A (en) Pharmaceutical composition comprising a substance inhibiting no synthase
EP0684044A3 (en) Composition containing a dendrimer and an active substance.
ES2039480T3 (en) A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE.
TR199902205T2 (en) Medicinal composition containing a lipophilic inert gas.
DE69634670D1 (en) ACTIVE ANODE MATERIAL AND NON-WATER SECONDARY BATTERY
TR200200982T2 (en) Pharmaceutical composition compositions.
TR200100093T2 (en) Detergent tablet
TR199902396T2 (en) Analgesic joint.
DE69813602D1 (en) VENLAFAX-CONTAINING MEDICINE WITH EXTENDED ACTIVE SUBSTANCE
TR199902175T2 (en) Swallowing tablet containing paracetamol.
TR199901413T2 (en) New treatment for joint inflammation.
IT1287174B1 (en) PHARMACOLOGICALLY ACTIVE DIARYL-CYCLOMETHYLENPYRAZOLES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
TR199903209T2 (en) Pharmaceutical composition.
TR200503846T2 (en) Alternative use for modified release insulin sensitiser and use
DE3070184D1 (en) Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
DE3068074D1 (en) Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
EE04347B1 (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, medicament and pharmaceutical composition containing them
AR019331A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN INSULIN SENSITIZER AND AN INSULIN SECRETAGOG.